Cowen Remains Bullish on Cowen ITT Corp. (ITT) as the Company Supplements High-Performance Auto Business

Go back to Cowen Remains Bullish on Cowen ITT Corp. (ITT) as the Company Supplements High-Performance Auto Business

Notable Mergers and Acquisitions 8/31: (FOLD) (ITT) (KANG) (NX)

August 31, 2015 9:51 AM EDT

* Amicus Therapeutics (NASDAQ: FOLD) and Scioderm, Inc. a privately-held biopharmaceutical company focused on developing innovative therapies for treating diseases with high unmet need, have signed a definitive agreement under which Amicus will acquire 100% of the capital stock of Scioderm, Inc.

Transaction highlights

Excellent strategic fit with Amicus' patient-centric vision to develop and commercialize advanced therapies for devastating rare and orphan diseasesLeverages Scioderm development team's EB expertise with Amicus' global clinical infrastructure to advance Zorblisa toward regulatory approvals and Amicus' commercial, patient advocacy and medical affairs infrastructure to support a successful global... More

ITT Corp. (ITT) to Acquire Wolverine Automotive in $300M Deal

August 31, 2015 9:01 AM EDT

ITT Corp. (NYSE: ITT) has signed an agreement to acquire Wolverine Automotive Holdings Inc., the parent company of Wolverine Advanced Materials LLC (Wolverine), a global market leader in developing and manufacturing customized technologies for automotive braking systems and specialized sealing solutions for harsh operating environments across a range of industries. Founded in 1934, Wolverine is a globally diversified manufacturer with a strong reputation for material science-based solutions and meaningful aftermarket content representing approximately 40 percent of revenue.

The acquisition of Wolverine, which will vertically integrate an existing automotive supplier, will also give ITT the opportunity to... More